Overview
The primary endpoint of this study is the completion time of hemostasis treatment when administered Fresh frozen plasma (FFP) and frozen powder coagulation factor concentrate (PCC) in goal-directed bleeding management for cardiac surgery.
Eligibility
Inclusion Criteria:
- patients undergoing cardiac surgery
Exclusion Criteria:
- thrombocytopenia
- oral anti-coagulant
- anti platelet agents


